The 14-day relative strength index on European Lithium has dipped to 29.9, pushing the stock into oversold territory for the first time in weeks. The technical trigger arrives as shares extend a punishing 30-day slide that has wiped 33.8% from the price, leaving the stock at €0.1718 after an 8.32% drop on Friday alone. Yet behind the bearish momentum lies a corporate event that could reshape the equity from the ground up — the planned takeover by Nasdaq-listed Critical Metals Corp is approaching a pivotal vote window.
Investors have been selling first and asking questions later. The sell-off was not confined to Frankfurt: on the US OTC market (ticker EULIF) shares crashed 13.53% to $0.20 on July 17, while on the Australian Stock Exchange (EUR.AX) the stock slipped 1.52% to A$0.325 the same week. The annualized 30-day volatility has ballooned to 83.61%, a level that underscores just how jittery trading has become as the market digests both the merger timeline and the broader sentiment in the lithium sector.
The scheme booklet that will formalize the merger terms is expected to be released by the end of July or early August 2026. It will contain an independent expert’s report that shareholders and option holders must approve under Australian law. If all goes smoothly — court and shareholder approvals obtained — the transaction should close in September. Upon completion, current European Lithium shareholders will own roughly 41% of the combined entity. In a newly added convenience mechanism, holders of 50,000 or fewer shares or options will be able to use a dedicated sale facility: a selling agent will automatically market their allotted Critical Metals shares on the open exchange.
Should investors sell immediately? Or is it worth buying European Lithium?
Against that backdrop, the stock’s chart is flashing multiple warning signals. The 52-week high of €0.3055, set only on June 2, now lies 43.76% behind. On the Australian board, where the beta is 2.56, technical support is pegged at A$0.285 and resistance at A$0.365. The price has already broken below the A$0.325 close, and a further leg down would test the 200-day moving average of €0.1635 — a level the stock is currently just 5% above. Some quantitative models, however, see a potential 14.42% recovery over three months, targeting a range of A$0.336 to A$0.589.
Paradoxically, the long-term picture remains strikingly positive. Year-to-date the stock is still up roughly 90%, and over twelve months the gain is an extraordinary 277%. That asymmetry — a massive rally followed by a brutal correction — explains much of the current tension. The short-term technicals have turned decisively bearish (the RSI below 30, the June 26 sell signal on the ASX costing the stock 14.47% since then), yet the merger catalyst has not yet materialized. Until the scheme booklet lands and investors can assess the precise valuation being offered, uncertainty is likely to keep volatility elevated.
The critical test will come when the booklet is published, potentially in the next few weeks. If the independent valuation supports the deal’s terms, the oversold condition could attract buyers looking for a discount ahead of the September closing. If it disappoints, the next major support near the 200-day average may come into play. For now, European Lithium remains in the grip of two competing forces: a technical washout that suggests exhaustion among sellers, and a fundamental event that has yet to deliver clarity.
Ad
European Lithium Stock: Buy or Sell?! New European Lithium Analysis from July 18 delivers the answer:
The latest European Lithium figures speak for themselves: Urgent action needed for European Lithium investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 18.
European Lithium: Buy or sell? Read more here...
